NR3C2 and chronic kidney disease: The present study shows that 24 weeks add-on of the selective aldosterone receptor inhibitor, eplerenone, in CKD stage 3–4 had no effect on cfPWV, but caused a significant effect on the pulse wave reflection judged by AIx and AIx@HR75, which tended to decrease in the eplerenone group and increased in the control group.